Post-earnings recap
Reported
Thu, Mar 13, 2025
EPS actual
$-0.46
EPS est.
$-0.53
EPS surprise
+13.70%
1-day move
-3.47%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Enliven Therapeutics reported a narrower-than-expected loss per share, which was a positive surprise. However, the stock fell by 3.47% in reaction, indicating that investors may have been looking for more comprehensive updates or guidance that was not provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.46 | N/A | +13.70% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.